Briya, a healthtech AI company, has appointed Professor Jonathan M. Samet as Chief Epidemiologist to enhance its AI-driven clinical research capabilities. This strategic move aims to integrate robust epidemiological methodologies into Briya’s AIRE research engine, ensuring that AI can generate credible evidence for medical studies.
The integration of epidemiology is pivotal for Briya’s mission to refine AI from a general tool into a specialized research system. By embedding medical reasoning and study design principles into AI workflows, Briya seeks to align its platform with established clinical research standards, addressing challenges in healthcare data analysis.
Professor Samet, with over 40 years of experience in epidemiology and public health, will play a crucial role in ensuring that Briya’s platform adheres to core clinical research principles. His extensive background includes leadership roles at prominent institutions and membership in the National Academy of Medicine, underscoring his expertise in the field.
Briya plans to showcase its innovative epidemiology-focused research capabilities at HLTH Europe, emphasizing how its AI platform can enhance clinical and biomedical research workflows. By prioritizing a federated data approach and ensuring full anonymization, the company aims to foster trust and compliance while accelerating advancements in medical research.
This appointment reflects a commitment to merge scientific rigor with AI technology, addressing the industry's need for trustworthy tools in complex medical contexts. As AI becomes increasingly integral to medical research, maintaining transparency and scientific validity will be essential for building trust among researchers and clinicians.